Tuesday, April 28, 2026

End of Suffering: Abandoned Animals in South Korean Zoo Find Hope in New Home

Animals that were overlooked for several years...

Discover Signiq: The K-Beauty Brand Launching a Unique Jelly Bear Pop-Up Store in Seoul

Signiq launches a pop-up store in Seoul featuring its Plumping Peptide Line, offering fun activities and new skincare products.

NOW A SERVANT?: South Korea Was A Puppet State, Refusing To Condemn North Korea’s Human Rights MASSACRE

South Korea rejoined as a co-sponsor of a UN resolution on North Korean human rights, condemning abuses and seeking accountability.

Tag: ALT-B4

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

Alteogen and Biogen: A Game-Changing 200 Million USD License Deal for ALT-B4 Biopharmaceuticals

Alteogen partners with Biogen for exclusive licensing of subcutaneous biopharmaceuticals, potentially earning up to 549 million USD.

Alteogen Secures U.S. Patent for Keytruda Subcutaneous Injection: What This Means for ALT-B4 and Future Treatments

Alteogen secures a U.S. patent for a subcutaneous Keytruda formulation using ALT-B4, ensuring exclusivity until 2043 and potential $1B in sales.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.